2024
Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study
Puklin L, Irwin M, Sanft T, Ferrucci L, Harrigan M, McGowan C, Cartmel B, Zupa M, Winer E, Deyling M, Ligibel J, Basen-Engquist K, Spiegelman D, Sharifi M. Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study. Supportive Care In Cancer 2024, 32: 590. PMID: 39141176, DOI: 10.1007/s00520-024-08789-5.Peer-Reviewed Original ResearchConceptsPhysical activityLifestyle interventionSelf-reported PA questionnaireSelf-reported diet qualityBreast cancerHealthy Eating Index-2015Stage I-III breast cancerBenefits of PASequential mixed methods studyI-III breast cancerChemotherapy-related symptomsMixed methods studyThematic content analysisBehavioral goalsSense of controlBody mass indexPA questionnaireSemi-structured interviewsMean body mass indexTranscribed verbatimIntervention armTailored educationDiet qualityNutritional behaviorMental benefits
2023
Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study
Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li F, Ferrucci L, Puklin L, Cao A, Nguyen T, Neuhouser M, Hershman D, Basen-Engquist K, Jones B, Knobf T, Chagpar A, Silber A, Tanasijevic A, Ligibel J, Irwin M. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal Of Clinical Oncology 2023, 41: 5285-5295. PMID: 37656930, PMCID: PMC10691793, DOI: 10.1200/jco.23.00871.Peer-Reviewed Original ResearchConceptsRelative dose intensityPathologic complete responseProportion of patientsBreast cancerNeoadjuvant chemotherapyChemotherapy completionComplete responseNutrition interventionsHigher pathologic complete responseHuman epidermal growth factor receptor 2Epidermal growth factor receptor 2Triple-negative breast cancerChemotherapy dose adjustmentsHome-based exerciseGrowth factor receptor 2Breast cancer outcomesEffects of exerciseFactor receptor 2Electronic medical recordsChi-square testUsual careDose intensityExercise interventionDose adjustmentRandomized trials
2022
Letter to the Editor: Differentiating Between Intentional Versus Unintentional Weight Loss.
Puklin L, Irwin ML, Sanft T, Ferrucci LM. Letter to the Editor: Differentiating Between Intentional Versus Unintentional Weight Loss. Journal Of The National Comprehensive Cancer Network 2022, 20: xliv. PMID: 34991074, DOI: 10.6004/jnccn.2021.7052.Peer-Reviewed Original ResearchHumansWeight Loss
2014
Plasma Adiponectin, Clinical Factors, and Patient Outcomes during the Acute Respiratory Distress Syndrome
Walkey A, Demissie S, Shah D, Romero F, Puklin L, Summer R. Plasma Adiponectin, Clinical Factors, and Patient Outcomes during the Acute Respiratory Distress Syndrome. PLOS ONE 2014, 9: e108561. PMID: 25259893, PMCID: PMC4178176, DOI: 10.1371/journal.pone.0108561.Peer-Reviewed Original ResearchConceptsAcute respiratory distress syndromeAPN levelsRespiratory distress syndromeBaseline adiponectinLung injuryClinical factorsDistress syndromeDay 7Cox proportional hazards regression modelProportional hazards regression modelsCatheter Treatment TrialDirect pulmonary injuryHigher APN levelsPlasma APN concentrationPlasma APN levelsPulmonary artery pressureRetrospective cohort studyRight heart catheterizationAcute lung injuryCentral venous pressureMultivariable-adjusted modelsAnti-inflammatory hormonePast medical historySeverity of illnessBody mass index